Need a specific person's email?
Browse BIND Therapeutics's employee directory (about 4 employees) and reveal verified emails free.
BIND Therapeutics's most common email format is FLast@bindtherapeutics.com (ex. JDoe@bindtherapeutics.com), used for 29% of bindtherapeutics.com addresses. BIND Therapeutics uses 4 email patterns.
| Format | Example | Share of bindtherapeutics.com |
|---|---|---|
| FLast@bindtherapeutics.comMost common | JDoe@bindtherapeutics.com | |
| Last@bindtherapeutics.com | Doe@bindtherapeutics.com | |
| FirstLast@bindtherapeutics.com | JohnDoe@bindtherapeutics.com | |
| First.Last@bindtherapeutics.com | John.Doe@bindtherapeutics.com |
Browse BIND Therapeutics's employee directory (about 4 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States2-10 Employees
BIND Therapeutics is a biotechnology company founded in 2006 and based in Cambridge, Massachusetts. Its work centers on developing targeted drug delivery systems designed to direct therapeutic agents to specific cells and tissues involved in disease, aiming to enable treatment approaches not achievable with conventional methods. The company’s primary focus has been on ACCURINS, proprietary nanoparticles intended to enhance targeting and therapeutic outcomes, with ongoing development activity in collaboration with Pfizer. The market for BIND’s work lies in oncology and other areas where precise delivery can improve treatment effectiveness. Its location in the Cambridge biopharma ecosystem places it among a concentration of research-focused firms pursuing advanced delivery technologies. Recent developments include collaborations with Pfizer related to the continued development of ACCURINS, reflecting ongoing partnerships within the pharmaceutical industry.
Most common format
FLast@bindtherapeutics.com
Example: JDoe@bindtherapeutics.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.